Image pharmaphorum Editor News Keytruda approved for combination lung cancer therapy The US Food and Drug Administration (FDA) has approved Merck & Co’s Keytruda plus chemotherapy as a first-line treatment for non-small cell lung cancer (NSCLC). News Amazon sells exclusive diabetes and hypertension devices Amazon has launched an exclusive range of medical devices to help people manage their diabetes and hypertension at home. News UK opens doors to cannabis-based therapies via NHS Medical cannabis is available to certain patients across the UK for the first time from today. News FDA approves biosimilar of blockbuster Humira A Humira biosimilar, produced by drug maker Sandoz, has been given the green light from the US Food and Drug Administration (FDA). Load more results
News Keytruda approved for combination lung cancer therapy The US Food and Drug Administration (FDA) has approved Merck & Co’s Keytruda plus chemotherapy as a first-line treatment for non-small cell lung cancer (NSCLC).
News Amazon sells exclusive diabetes and hypertension devices Amazon has launched an exclusive range of medical devices to help people manage their diabetes and hypertension at home.
News UK opens doors to cannabis-based therapies via NHS Medical cannabis is available to certain patients across the UK for the first time from today.
News FDA approves biosimilar of blockbuster Humira A Humira biosimilar, produced by drug maker Sandoz, has been given the green light from the US Food and Drug Administration (FDA).
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.